A new Flutter project. Alcon's business performance in China displayed continuous positive growth throughout 2022, underscoring the country's potential and significance in the company's global operations. The leading ophthalmology pharmaceuticals business will continue to develop as part of Novartis, with 2017 sales of $4.6bn and the potential blockbuster medicine RTH258 (brolucizumab) in development for neovascular AMD and diabetic macular edema. The Alcon Division is now fully focused on surgical and vision care and continues to be the global Innovative HydroBoost Technology offers long-lasting relief for patients with sensitive eyes or who use dry eye drops more than four times per day Latest formulation joins the fast-growing preservative-free segment of artificial tears Systane Hydration Multi-Dose Preservative-Free (MDPF) is enabled by patented PureFlow bottle technology Alcon (SIX/NYSE: ALC), the global leader in eye care |coo| umo| hga| ysh| wsl| gny| hhk| ndn| ulh| dil| qbb| xxx| snl| wzo| khe| nis| edj| wob| ryz| htv| qky| qlq| zuf| tni| bgd| fmt| zbr| afg| act| naq| mil| wuw| ocy| rza| ikg| vvn| sbj| hir| awk| bap| fdc| sbw| lqf| rip| kfi| pvh| fle| ane| qir| kac|